Comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients: Findings from CALGB 89803 and CALGB 80405 Journal Article


Authors: Van Loon, K.; Wigler, D.; Niedzwiecki, D.; Venook, A. P.; Fuchs, C.; Blanke, C.; Saltz, L.; Goldberg, R. M.; Meyerhardt, J. A.
Article Title: Comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients: Findings from CALGB 89803 and CALGB 80405
Abstract: Background: Cancer patients often pursue lifestyle and dietary changes with the aim to improve outcomes. Using data from 2 large National Cancer Institute-sponsored clinical trials, we report on the dietary and lifestyle practices of patients receiving therapy for stage III colon or metastatic colorectal cancer. Patients and Methods: Self-administered questionnaires were completed by patients undergoing chemotherapy for stage III colon cancer (n = 1095) and metastatic colorectal cancer (n = 875). Descriptive statistical analyses were performed to evaluate anthropometrics, diet, and lifestyle in each cohort. Results: Median body mass index was comparable for stage III and metastatic patients (27.3 vs. 26.5 kg/m2). Stage III patients reported a modestly higher median level of physical activity than metastatic patients (4.6 vs. 3.4 metabolic equivalent task-hours per week). Ten percent of stage III and 9% of metastatic patients reported ongoing cigarette use. Avoidance of alcohol was reported by 47% of stage III and 43% of metastatic patients. Dietary patterns for both groups were comparable with more than 80% of stage III and metastatic patients failing to meet the recommended daily intake of vegetables, fruits, and milk products. Usage of at least 2 multivitamins per week was reported by 49% of stage III and 40% of metastatic patients. Two percent of stage III and 5% of metastatic patients reported vitamin D supplement use. Conclusions: We observed notable similarities in dietary and lifestyle behaviors between stage III colon and metastatic colorectal cancer patients actively receiving chemotherapy. Future research should aim to elucidate the effect of these behaviors on patient outcomes. © 2013 Elsevier Inc. All rights reserved.
Keywords: cancer chemotherapy; major clinical study; cancer patient; chemotherapy; outcome assessment; neoplasm staging; colorectal cancer; cohort studies; prevalence; exercise; health behavior; food habits; smoking; questionnaires; colorectal neoplasms; questionnaire; cancer center; body mass; colon cancer; vitamin d; neoplasm metastasis; vitamin supplementation; anthropometry; fruit; vegetable; dietary supplements; alpha tocopherol; folic acid; physical activity; phase 3 clinical trial; motor activity; retinol; zinc; dietary intake; beta carotene; vitamin b complex; alcohol drinking; lifestyle; life style; cyanocobalamin; nutrition; vitamins; pyridoxine; behavioral patterns; metabolic equivalent; nutrition policy
Journal Title: Clinical Colorectal Cancer
Volume: 12
Issue: 2
ISSN: 1533-0028
Publisher: Elsevier Inc.  
Date Published: 2013-06-01
Start Page: 95
End Page: 102
Language: English
DOI: 10.1016/j.clcc.2012.11.002
PROVIDER: scopus
PUBMED: 23317558
PMCID: PMC3790266
DOI/URL:
Notes: --- - "Export Date: 3 June 2013" - "CODEN: CCCLC" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Leonard B Saltz
    791 Saltz